EGFR and non-small cell lung carcinoma: Recently, it was demonstrated that there was a positive association between tumors with EGFR mutations and higher rates of pain in response to palliative radiotherapy in an analysis of NSCLC patient-reported outcomes [71], further supporting the involvement of EGFR in both cancer progression and pain signaling.